Sukumar Nagendran, M.D.

President and Head of Research and Development

Suku brings more than 25 years of experience in gene therapy development, clinical development strategy, medical affairs, diagnostics, payer strategy and commercialization of therapeutic products; also currently advising many other gene therapy and healthcare companies. Formerly of Jaguar Gene Therapy, AveXis, Quest Diagnostics and Pfizer.